Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06767566 · ClinicalTrials.gov registry record · Phase 1

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

A Phase 1 study of Pain and Postpartum Depression, sponsored by Grace Lim, MD, MS.

Recruiting
Registry status
Phase 1
Development phase
50
Enrollment target
2
Study locations

NCT06767566 is a Phase 1 study of Pain and Postpartum Depression that is actively recruiting participants, run by Grace Lim, MD, MS. The registered enrollment target is 50 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06767566, a Phase 1 study of Pain and Postpartum Depression, is actively recruiting participants, sponsored by Grace Lim, MD, MS.

RECRUITING
Registry status
Phase 1
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to identify pharmacokinetics of postpartum ketamine infusion. This study will assess ketamine kinetics and metabolism in this setting. Ketamine is expected to exert different kinetics during the physiologic state of post-pregnancy. The goal in conducting this study is to better understand the pharmacokinetics and pharmacodynamics of postpartum ketamine infusion. A secondary goal is to compare these kinetics to reproductive age matched controls and to assess sex differences in ketamine pharmacokinetics. The peripartum group of this study will receive ketamine after cesarean delivery, while the control group will consist of non-pregnant female subjects and male subjects receiving the same infusion protocol.

Conditions Studied

Pain Postpartum Depression

Interventions

  • DRUG Ketamine (Ketalar)

Study Locations (2)

Pennsylvania

  • Magee Womens Hospital of UPMC - Pittsburgh
  • UPMC Montefiore Clinical and Translational Research Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-03-28
Est. Completion 2028-03
Phase Phase 1

Sponsor

Grace Lim, MD, MS

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06767566

The ClinicalTrials.gov registry entry for NCT06767566 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The listed sponsor is Grace Lim, MD, MS, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Ketamine (Ketalar) is the first listed.

NCT06767566 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06767566 about?

NCT06767566 is a clinical study titled "Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery". The purpose of this study is to identify pharmacokinetics of postpartum ketamine infusion. This study will assess ketamine kinetics and metabolism in this setting. Ketamine is expected to exert different kinetics during the physiologic state of post-pregnancy. The goal in conducting this study is to...

What is the current status of trial NCT06767566?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2025-03-28. Estimated completion is 2028-03.

What conditions does trial NCT06767566 study?

This clinical trial studies the following conditions: Pain, Postpartum Depression.

What interventions are being tested in trial NCT06767566?

The interventions under investigation include: Ketamine (Ketalar) (DRUG).

Who is sponsoring clinical trial NCT06767566?

This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06767566 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Postpartum Depression

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.